IL162827A0 - A process for producing phenserine and its analog - Google Patents

A process for producing phenserine and its analog

Info

Publication number
IL162827A0
IL162827A0 IL16282702A IL16282702A IL162827A0 IL 162827 A0 IL162827 A0 IL 162827A0 IL 16282702 A IL16282702 A IL 16282702A IL 16282702 A IL16282702 A IL 16282702A IL 162827 A0 IL162827 A0 IL 162827A0
Authority
IL
Israel
Prior art keywords
phenserine
analog
producing
compounds
isocyanate
Prior art date
Application number
IL16282702A
Other languages
English (en)
Original Assignee
Axonyx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axonyx Inc filed Critical Axonyx Inc
Publication of IL162827A0 publication Critical patent/IL162827A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL16282702A 2002-01-09 2002-12-11 A process for producing phenserine and its analog IL162827A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/042,586 US6495700B1 (en) 2002-01-09 2002-01-09 Process for producing phenserine and its analog
PCT/US2002/039537 WO2003059909A1 (fr) 2002-01-09 2002-12-11 Processus de production de phenserine et de ses analogues

Publications (1)

Publication Number Publication Date
IL162827A0 true IL162827A0 (en) 2005-11-20

Family

ID=21922704

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16282702A IL162827A0 (en) 2002-01-09 2002-12-11 A process for producing phenserine and its analog

Country Status (16)

Country Link
US (1) US6495700B1 (fr)
EP (1) EP1463729B1 (fr)
JP (1) JP2005514459A (fr)
KR (2) KR100712003B1 (fr)
CN (1) CN1301995C (fr)
AT (1) ATE466015T1 (fr)
AU (1) AU2002353102B2 (fr)
BR (1) BRPI0215492A2 (fr)
CA (1) CA2470560C (fr)
DE (1) DE60236207D1 (fr)
HK (1) HK1075659A1 (fr)
HR (1) HRP20040606A2 (fr)
HU (1) HUP0500747A3 (fr)
IL (1) IL162827A0 (fr)
PL (1) PL374240A1 (fr)
WO (1) WO2003059909A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1689704A2 (fr) 2003-10-21 2006-08-16 CoLucid Pharmaceuticals, Inc. Esters de carbamoyle inhibant la cholinesterase et liberant des agents pharmacologiquement actifs
US20070167509A1 (en) * 2005-06-14 2007-07-19 Joseph Araujo Use of phenserine and analogs to treat behavioral problems and improve trainability
EP2258359A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
AU2007292848A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
WO2011100373A1 (fr) 2010-02-09 2011-08-18 The Johns Hopkins University Procédés et compositions pour améliorer la fonction cognitive
US20120225922A1 (en) 2011-03-04 2012-09-06 Qr Pharma Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
US20130096316A1 (en) * 2011-10-14 2013-04-18 Qr Pharma, Inc. Novel Method for Preparation of Bisnorcymerine and Salts Thereof
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
CN105142623A (zh) 2013-03-15 2015-12-09 艾吉因生物股份有限公司 用于改善认知功能的方法和组合物
EP2968237A4 (fr) 2013-03-15 2016-08-31 Univ Johns Hopkins Procédés et compositions pour améliorer la fonction cognitive
US10159648B2 (en) 2015-05-22 2018-12-25 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
CA3083015A1 (fr) 2017-05-24 2018-11-28 Qr Pharma, Inc. Prevention ou traitement d'etats pathologiques dus a une dys-homeostasie des metaux par administration de posiphene a des sujets humains sains ou malades

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1109003B (it) * 1977-09-20 1985-12-16 Univ Firenze Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo
US5306825A (en) 1984-03-01 1994-04-26 Consiglio Nazionale Delle Ricerche Physostigmine derivatives with acetylcholinesterase inhibition properties, and the relative production process
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4791107A (en) 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
IT1225462B (it) * 1987-04-03 1990-11-14 Mediolanum Farmaceutici Srl Sali organici di derivati della fisostigmina
US5187165A (en) 1987-05-15 1993-02-16 Hoechst-Roussel Pharmaceuticals Inc. Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
US4900748A (en) 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents
US5260452A (en) 1989-11-03 1993-11-09 Hoechst-Roussel Pharmaceuticals Inc. 4- and 6-carbamates related to physostigmine and intermediates for the preparation thereof
US5077289A (en) 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5177101A (en) 1989-11-30 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5705657A (en) 1991-02-14 1998-01-06 Labochim Laboratorio Chimico Internazionale S.P.A. Isocyanate process for the preparation of 1,3A,8-trimethyl-1,2,3,3A, 8, 8A-hexahydro-pyrrole 2,3-B! indol-5 (3AS, 8AR) -hepthylcarbamate
EP0499959A1 (fr) 1991-02-18 1992-08-26 Bromine Compounds Ltd. Procédé pour la préparation des maléimides substitués
WO1993006105A1 (fr) 1991-09-26 1993-04-01 United States Government, As Represented By Secret Phenserines et phenylcarbamates substitues de (-)-eseroline, (-)-n1-noreseroline, et (-)-n1-benzylnoreseroline utilises comme inhibiteurs specifiques de l'acetylcholinesterase
US5206260A (en) 1991-11-07 1993-04-27 Merck & Co., Inc. Hexahydropyrrolo[2,3-b]indole derivatives
US5302721A (en) 1992-07-21 1994-04-12 Hoechst-Roussel Pharmaceuticals Incorporated Method of preparation of physostigmine carbamate derivatives from eseretholes
PH30885A (en) * 1992-07-21 1997-12-23 Hoechst Roussel Pharma Preparation of physostigmie carbamate derivatives from physostigmine.
US5409948A (en) 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
US5665880A (en) 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers

Also Published As

Publication number Publication date
KR20040072711A (ko) 2004-08-18
KR100712003B1 (ko) 2007-05-02
CA2470560C (fr) 2007-05-15
EP1463729B1 (fr) 2010-04-28
BRPI0215492A2 (pt) 2016-07-05
US6495700B1 (en) 2002-12-17
EP1463729A4 (fr) 2005-06-29
AU2002353102B2 (en) 2007-05-24
HUP0500747A3 (en) 2009-05-28
HK1075659A1 (en) 2005-12-23
HRP20040606A2 (en) 2004-12-31
HUP0500747A2 (hu) 2005-11-28
DE60236207D1 (de) 2010-06-10
EP1463729A1 (fr) 2004-10-06
CN1612880A (zh) 2005-05-04
JP2005514459A (ja) 2005-05-19
WO2003059909A1 (fr) 2003-07-24
KR20060097772A (ko) 2006-09-15
CA2470560A1 (fr) 2003-07-24
ATE466015T1 (de) 2010-05-15
PL374240A1 (en) 2005-10-03
AU2002353102A1 (en) 2003-07-30
CN1301995C (zh) 2007-02-28

Similar Documents

Publication Publication Date Title
HK1075659A1 (en) A process for producing phenserine and its analog
MXPA04006677A (es) Procedimiento para la preparacion de esteres de escopina.
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
UA89390C2 (ru) Способ получения аннелированных производных пиперазин-2-она та соответствующие промежуточные продукты
TNSN05105A1 (en) Novel bicyclic inhibitors of hormone sensitive lipase
IL179749A0 (en) Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
IL175253A0 (en) A process for preparing pyrrole derivatives
GB0222056D0 (en) Process for the manufacture of organic compounds
MXPA04007396A (es) Proceso para la elaboracion de inhibidores de reductasa hmg-coa.
MXPA05008183A (es) Proceso para preparar pirrolotriazina como inhibidores de cinasa.
IL162817A0 (en) Process for the manufacture of organic compounds
WO2004043918A3 (fr) Nouvelles formes cristallines d'atorvastatine hemi-calcium et leurs procedes de preparation ainsi que de nouveaux procedes de preparation d'autres formes
GB0204129D0 (en) Process for the manufacture of organic compounds
MY145842A (en) Method of producing triethanolamine
WO2006036926A3 (fr) Synthese efficace de 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
TW200626606A (en) Process for preparing phosphorus compounds having phosphate-phosphonate bond
UA85428C2 (ru) Способ получения с-2, с-3 замещенных n-алкилированных индолов, а также промежуточные соединения и способы их получения
TW200942546A (en) A crystalline form of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one
GB0210234D0 (en) Process for the manufacture of organic compounds
AU2003267565A8 (en) Process for the production of a fuel composition
WO2006043175A3 (fr) Procede de preparation de composes puriques
TW200624435A (en) Process for preparing iridium(Ⅲ) ketoketonates
GB0010475D0 (en) Organic compounds
IL146811A0 (en) Novel method for preparing benzoperhydroisoindole compounds
WO2007096903A3 (fr) Nouvelle forme cristalline d'hemi-calcium d'atorvastatine